Loading
Hilary Eaton

Hilary Eaton

Chief Business Officer, Profluent Bio
United States
Dr. Hilary Eaton is the Chief Business Officer at Profluent Bio, an AI-first protein design company initially focusing on gene editing. Dr. Eaton has more than a decade of experience in BD and strategy at leading gene editing companies, including Editas, Vor and Tome. Prior to her career in business development, she received her PhD from Duke University and completed a postdoc at Harvard Medical School / Dana-Farber Cancer Institute.
Sessions
  • 04-Jun-2024
    Company Presentation Theater 4
    Profluent Bio

BIO DOUBLE HELIX SPONSOR

Our sponsors help support BIO's mission to support and advocate for the biotechnology industry.

Loading

BIO HELIX SPONSORS